Medical Condition News

RSS

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

A new study by Baylor University environmental health researchers found that zebra fish exposed to several different technical mixtures of polybrominated diphenyl ethers (PBDEs) - a common fire retardant - during early development can cause developmental malformations, changes in behavior and death.

25 May 2011

Moderate drinking does not increase risk of fatty liver disease

In a large study of men in Japan, the presence of fatty liver disease by ultrasonography showed an inverse ( reduced risk) association with the frequency of moderate alcohol consumption; however, there was some suggestion of an increase in fatty liver disease with higher volume of alcohol consumed per day.

25 May 2011

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

In a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating complete eradication of the cancer in cell and animal studies.

25 May 2011

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

Crescendo Bioscience- today announced data indicating that Vectra- DA, a first-in-class multi-biomarker blood test used to assess rheumatoid arthritis disease activity, provides physicians with an objective measure which may help determine whether patients are responding to therapy.

25 May 2011

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

25 May 2011

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues.

25 May 2011

Brisk walking may delay or even prevent progression of prostate cancer in men

Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.

25 May 2011

Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast cancer

Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.

25 May 2011

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.

25 May 2011

Fibre rich diet and healthy lifestyle prevents bowel cancer

According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now “convincing” evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber “probably” cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.

24 May 2011

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual in its Phase 2C clinical trial of PH-10 for the treatment of psoriasis. PH-10, an aqueous hydrogel formulation of Rose Bengal disodium for topical administration to the skin, is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis.

24 May 2011

Nanoscopic findings may lead to new experimental methods for early multiple sclerosis diagnosis

Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis -- and to possible treatments -- for pathological tissues that are precursors to multiple sclerosis and similar diseases.

24 May 2011

Disaster-response planning raises challenges for mental health services, bioethicists say

Johns Hopkins University bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions.

24 May 2011

People who have close relative with type I alcoholism react more positively to alcohol

Scientists have long known that people who have a close relative with alcohol problems themselves run an increased risk of starting to abuse alcohol. The reason for this has not been known, but a new study from the University of Gothenburg, Sweden, provides part of the answer.

24 May 2011

Israel President announces launch of new international centre for brain research

On the opening of the ILSI Biomed Israel 2011 week, President Peres has announced the launch of a new international centre in Israel, set to conduct brain research and to promote the neuro-technology field.

24 May 2011

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

In a new important research study out of the UK, scientists found that the specific form of Modified Citrus Pectin developed by Isaac Eliaz, M.D. interrupts deadly kidney fibrosis by binding to galectin-3 molecules, decreasing the effects of inflammation and fibrosis in acute kidney injury.

24 May 2011

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

A rare genetic disease called dyskeratosis congenita, caused by the rapid shortening of telomeres, can be mimicked through the study of undifferentiated induced pluripotent stem cells, according to new findings from the Stanford University School of Medicine.

24 May 2011

Insight into obsessive-compulsive disorder

New scientific evidence challenges a popular conception that behaviours such as repetitive hand-washing, characteristic of obsessive-compulsive disorder, are carried out in response to disturbing obsessive fears.

24 May 2011

National Council on Skin Cancer Prevention 'Don't Fry Day' campaign to encourage sun safety awareness

Despite skin cancer's being largely preventable, it remains by far the most common type of cancer in the United States. There are over two million new cases of skin cancer diagnosed annually, which is more than new cases of breast, prostate, lung and colon cancers combined.

24 May 2011

3M, Radius collaborate to develop BA058 for treatment of osteoporosis

Radius Health, Inc. and 3M Drug Delivery Systems today announced an agreement to collaborate on the development of a transdermal delivery option of BA058, Radius' novel, proprietary PTHrP analog, for the treatment of osteoporosis.

24 May 2011

Medical Condition News

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

Moderate drinking does not increase risk of fatty liver disease

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

New data on why aging brain is less resilient and less capable of learning from life experiences

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

Brisk walking may delay or even prevent progression of prostate cancer in men

Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast cancer

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

Fibre rich diet and healthy lifestyle prevents bowel cancer

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis

Nanoscopic findings may lead to new experimental methods for early multiple sclerosis diagnosis

Disaster-response planning raises challenges for mental health services, bioethicists say

People who have close relative with type I alcoholism react more positively to alcohol

Israel President announces launch of new international centre for brain research

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

Insight into obsessive-compulsive disorder

National Council on Skin Cancer Prevention 'Don't Fry Day' campaign to encourage sun safety awareness

3M, Radius collaborate to develop BA058 for treatment of osteoporosis

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News